Skip to content
OpenCapital
Get started

Myriad Genetics MYGN Operating Lease Liabilities (Current)

Operating Lease Liabilities (Current) at other companies

Labcorp Holdings logo
Labcorp HoldingsLH
$183.2M+0.2%
Quest Diagnostics logo
Quest DiagnosticsDGX
$174M+0.6%
NeoGenomics logo
NeoGenomicsNEO
$4.83M+57.0%
Veracyte logo
VeracyteVCYT
$4.35M-41.3%
Guardant Health logo
Guardant HealthGH
$28.03M-5.5%
Natera, Inc. logo
Natera, Inc.NTRA
$14.82M+21.5%

Segments

By geography

See full
West Salt Lake City$2.7M—

Other financials

Income statement

See full
Revenue$200.4M+2.3%
Gross profit$137.6M+2.5%
Operating income-$30.7M-5.9%
Net income-$34.1M-34,000%
EPS (diluted)-$0.36—

Balance sheet

See full
Cash & equivalents$126.0M+24.8%
Total debt$211.5M+34.2%
Total equity$337.4M-52.1%
Total assets$673.7M-33.0%

Cash flow

See full
Operating cash flow-$15.7M+3.7%
CapEx$18.8M+181%
Free cash flow-$19.7M+65.1%

Valuation

See full
Market cap$512.85M+13.1%
Enterprise value$598.35M+17.3%
P/S0.6×+0.1×

Profitability

See full
Gross margin70%0.0pp
Operating margin-46.9%-88.3pp
Net margin-48.2%-72.9pp
FCF margin-17%—

Returns & leverage

See full
Return on equity-76.7%-98.4pp
Debt / equity0.6×+0.4×
Current ratio2.4×+0.5×

Where this comes from

Reported directly by Myriad Genetics in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityCurrent.

The official record: Myriad Genetics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Myriad Genetics's operating lease liabilities (current).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Myriad Genetics's operating lease liabilities (current)?
Myriad Genetics (MYGN) reported operating lease liabilities (current) of $7.1M in Q1 2026.
How has Myriad Genetics's operating lease liabilities (current) changed year-over-year?
Myriad Genetics's operating lease liabilities (current) decreased by 34.9% year-over-year, from $10.9M to $7.1M.
What is the long-term trend for Myriad Genetics's operating lease liabilities (current)?
Over 5 years (2020 to 2025), Myriad Genetics's operating lease liabilities (current) has grown at a -12.7% compound annual growth rate (CAGR), from $13.6M to $6.9M.
What does operating lease liabilities (current) mean?
The current portion of operating lease obligations due within one year, representing committed future lease payments under ASC 842.